BackgroundThe aim of this study was to investigate the correlation between inflammatory biomarkers such as the systemic immune-inflammation index (SII), the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) and the recurrence of pleomorphic adenomas (PAs). MethodsRetrospective multicenter study. 608 patients diagnosed with PA and treated by tumor enucleation were included in the analyses. The patients. were extracted from a twenty-year database of two referral centers (January 2000 to January 2020). Data about age, sex, voluntary habits, tumor characteristics, tumor treatment and values of NLR, PLR and SII were collected. A receiver operating characteristic (ROC) curve was used to calculate the optimal cut-off values for SII, PLR and NLR. A linear regression model (LRM) and a non-linear logistic regression model (NLRM) were implemented for NLR, PLR and SII. ResultsAll three inflammatory parameters were statistically significant correlated to the recurrence of the tumor. The best performance was achieved by NLR (cut-off 2.960) with AUC = 0.91, accuracy of 96.1%, sensitivity of 78.4% and specificity of 97.2%, PPV = 64.4% and NPV = 98.6%. LRM and NLRM including all hematological parameters did not improve performance in terms of recurrence detection. ConclusionThe use of three inflammatory biomarkers could be a useful tool to predict recurrence of tumor in case of PA ≤ 3 cm. NLR in particular could be sensitive with a cut-off of 2.960. The use of NLR, PLR and SII could be a good reference point for surgical decision making and follow-up in clinical practice.